Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.

Marvell set fiscal 2028 revenue guidance of about $20 billion and a fiscal 2031 range of $70 billion to $90 billion, versus $8.2 billion in fiscal 2026 revenue; management also sees a roughly $400 billion addressable market by 2030. Shares jumped and were around $290, while the article notes the stock trades at about 43 times expected fiscal 2028 earnings and that the long-range targets lack disclosed customer commitments. At the prior 38%–40% adjusted operating-margin target, the fiscal 2031 revenue range implies about $27 billion–$36 billion in adjusted operating profit; custom-chip growth could pressure margins and the shares may be volatile.

Analysis

The key valuation risk is not simply whether Marvell grows, but whether custom-chip revenue converts into durable earnings. Hyperscaler-designed silicon can expand Marvell’s addressable work while substituting for merchant accelerators and networking products; that makes cloud capex a two-sided exposure for suppliers such as Nvidia and Broadcom, not an unambiguous sector tailwind. For Marvell, custom-program mix may also dilute gross margin even as revenue accelerates, so revenue beats without stable margin guidance could disappoint a stock priced on a long runway.

The customer-purchase mechanism matters more than the headline opportunity: discretionary buying and a customer warrant are not backlog. Treat the fiscal 2031 range as a scenario, not contracted demand. The wide range and dependence on continued hyperscaler investment make duration and estimate risk unusually high. Near term, rising fiscal 2028 expectations may support the shares; over 1–3 months, validate them against reported bookings/program ramps and gross-margin guidance. Over 6–18 months, watch whether custom deployments scale without persistent mix pressure and whether cloud customers sustain AI infrastructure budgets.

Contrarian read: the market may be capitalizing distant targets too confidently, but a near-term short is also vulnerable to further estimate upgrades. The better expression is measured exposure, not a binary bet on the 2031 endpoint. A sustained gross-margin decline alongside weaker growth would challenge the thesis; continued upward guidance with stabilization in margins would strengthen it.

Key Decisions for Investors

• If underweight, build MRVL exposure in tranches after the post-event jump rather than chasing a single opening print; keep position sizing modest given the long-dated, customer-discretionary assumptions.
• Use the next earnings updates to test the thesis: track custom-program revenue or bookings disclosures, gross-margin trajectory, and any revision to fiscal 2028 guidance. Treat growth deceleration plus further margin erosion as a trim/exit alert.
• Do not infer a committed $120 billion revenue stream from the Google arrangement. Verify actual customer purchases and program conversion before underwriting the out-year range.
• Avoid a forced options trade without implied-volatility and event-pricing data. If evaluating a hedge, compare MRVL with Broadcom and merchant-chip exposure only after checking relative valuation, estimate revisions, and business-mix differences.